These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8666746)

  • 41. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters.
    Ravikumar G; Ananthamurthy A
    J Cancer Res Ther; 2014; 10(3):671-5. PubMed ID: 25313758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
    Ravdin PM; Green S; Dorr TM; McGuire WL; Fabian C; Pugh RP; Carter RD; Rivkin SE; Borst JR; Belt RJ
    J Clin Oncol; 1992 Aug; 10(8):1284-91. PubMed ID: 1634918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.
    Enomoto Y; Morimoto T; Nishimukai A; Higuchi T; Yanai A; Miyagawa Y; Murase K; Imamura M; Takatsuka Y; Nomura T; Takeda M; Watanabe T; Hirota S; Miyoshi Y
    Int J Clin Oncol; 2016 Apr; 21(2):254-261. PubMed ID: 26338270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].
    Jacquemier J; Boudaoura T; Martin PM; Torrente M; Hassoun J
    Ann Pathol; 1991; 11(4):224-30. PubMed ID: 1958256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.
    Kunc M; Pęksa R; Cserni G; Iżycka-Świeszewska E; Łacko A; Radecka B; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Szwajkosz A; Biernat W; Senkus E
    Pathology; 2022 Apr; 54(3):269-278. PubMed ID: 35074178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oestrogen and progesterone receptors and response to endocrine therapy in Japanese breast cancer.
    Nomura Y; Takatani O; Sugano H; Matsumoto K
    J Steroid Biochem; 1980 May; 13(5):565-6. PubMed ID: 7392632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
    Romić-Stojković R; Gamulin S
    Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
    Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
    Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study.
    Su JM; Hsu HK; Chang H; Lin SL; Chang HC; Huang MS; Tseng HH
    Anticancer Res; 1996; 16(6B):3803-6. PubMed ID: 9042261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.
    Asogan AB; Hong GS; Arni Prabhakaran SK
    Singapore Med J; 2017 Mar; 58(3):145-149. PubMed ID: 27029805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison between radioligand and immunohistochemical assay of hormone receptors in primary breast cancer.
    Charalambous D; Kitchen PR; Stillwell RG; Smart PJ; Rode J
    Aust N Z J Surg; 1993 Aug; 63(8):637-41. PubMed ID: 8338483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
    Redkar AA; Kabre SS; Mittra I
    Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
    Calzada L; Salazar EL; Pedron Nuevo N
    Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
    Layfield LJ; Saria EA; Conlon DH; Kerns BJ
    J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.
    Thompson EW; Sung V; Lavigne M; Baumann K; Azumi N; Aaron AD; Clarke R
    Clin Exp Metastasis; 1999 May; 17(3):193-204. PubMed ID: 10432004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
    Kunc M; Biernat W; Senkus-Konefka E
    Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changing behavior of estrogen and progesterone receptors with metastasis or recurrence of breast cancer].
    Morimoto K; Koh M; Yamamoto A; Tamura K; Yamamoto K; Yamamoto K; Suehiro S
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):925-9. PubMed ID: 16835481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.
    Yu KD; Liu GY; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
    Breast; 2007 Jun; 16(3):307-15. PubMed ID: 17293115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.